Category Chronic Diseases
Press Release
Reverse Kidney Disease Naturally: Proven 3-Phase Plan
The Chronic Kidney Disease Solution introduces a science-backed 3-phase system for natural kidney support in 2025 - focusing on the gut-kidney axis, inflammation reduction, and lifestyle-based recovery across all CKD stages. Read More
Press Release
April is Sjögren’s Awareness Month: Amplifying Patient Voices and Driving Awareness for an Underrecognized and Serious Autoimmune Disease
House resolution, national campaign, and patient voices shine a spotlight on one of the most prevalent-but misunderstood-autoimmune diseases. Read More
Press Release
HemoFlow 500 Series, the Next Generation Blood Scale/Mixer Devices, Launch in the United States Market
US market share leader also launches HemoVue, an integrated cloud service that provides blood banks with streamlined management of devices and real-time operational visibility into all blood collection data. Read More
Press Release
Seraxis Announces Publication of Preclinical Data for a Novel Islet Replacement Therapy and Clinical Candidate SR-02 for Insulin-Requiring Diabetes; Oral Presentation at IPITA
Manuscript describes the unique character of a pancreatic endocrine cell population derived from a non-pluripotent stem cell that closely resembles native islets in composition and in vivo function. Dr. William Rust, CEO of Seraxis, will deliver a lecture at the IPITA-IXA-CTRMS Joint Congress on October 29 at 10:00 a.m. in San Diego entitled "Novel stem cell-derived islet-like clusters potently control rodent blood glycemia". Seraxis will be taking meetings at BIO-Europe, November 6-8, in Munich. Read More
Press Release
Seraxis to Provide Oral Update on Its Pancreatic Organoid Candidate for Functional Cure of T1D at the 59th Annual Meeting of the EASD
Dr. William Rust will give an oral presentation on Seraxis' proprietary technology for the production of therapeutic pancreatic organoids from pancreas-derived stem cells, as well as review initial diabetes model data of functional cure of Type 1 Diabetes. Seraxis' presentation, entitled "Stem-cell Derived Islets for Treating Diabetes", will be delivered in the session entitled "Transplantation of Islet and Stem Cells Today and Tomorrow". Read More
Press Release
Seraxis Announces Closing of Second VC Tranche and Successful Completion of Preclinical Studies of Pancreatic Organoids From Seraxis’ Novel Pancreas-Derived Stem Cells
Leadership team expanded with addition of Chief Corporate Development Officer, Ted Hibben, a 25-year venture-stage business development biotherapeutic industry veteran Total venture funding tops $50M to date Read More
Press Release
PureWay Compliance, Inc. Provides Safe Needle Disposal to Self Injecting Patients
PureWay Compliance, Inc. provides safe sharps (needles, syringes, etc.) disposal to patients that self inject at home and do not wish to discard their needles in the trash. With increasing awareness of the hazards of dirty needles, patients are looking for safe and eco-friendly options to safely dispose of sharps at home. PureWay since 2013 has provided over 300,000 patients with sharps disposal by mail systems through strategic agreements with pharmaceutical manufacturers, non-profits like SafeNeedleDisposal and through stewardship programs. Read More
Press Release
GerdLi: New Supplement for Heartburn Was Made by a Physician Who Sought Natural Heartburn Relief
After developing severe esophagitis and being prescribed life-long medications, Jimmy Minhas, a doctor and founder of GerdLi, researched and created the world's first natural supplement to relieve heartburn and acid reflux. Read More
Press Release
Diabeloop - Key Player in Therapeutic AI Applied to Insulin Delivery - Announces 70 Million Euros New Financing Round to Accelerate Its International Expansion
High-growth diabetes company Diabeloop closes its Series C financing round - led by LBO France, joined by Terumo Corporation, Innovacom and backed by Diabeloop's historical partners - to power the company's commercial roll-out and global expansion. Read More
Press Release
Happy Bob Integrates With Dexcom CGM to Provide a Playful Way to Engage With Real-Time Glucose Values and Improve Overall Self-Care
Happy Bob App offers Dexcom CGM users and their caregivers more ways to interact with their glucose data, including a real-time iOS widget, Apple Watch app, groups, gamification, and humorous personalized messages. Read More
Press Release
SNAQ Launches their Diabetes Management App in the US and Adds Leading Experts to the Advisory Board
After the success in Europe, the award-winning SNAQ App is now available for people living with diabetes in the United States. The app supports seamless integration with many popular glucose sensors and diabetes apps. Alongside this launch, Anton Kittelberger, Dr. David Kerr and John Sjolund are newly joining the Advisory Board of SNAQ. Read More
Press Release